Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis

Trial Profile

A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jan 2019

At a glance

  • Drugs MSB 0011359C (Primary)
  • Indications Recurrent respiratory papillomatosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2018 Planned initiation date (estimated date of first participant enrollment) changed from 3 Dec 2018 to 25 Dec 2018.
    • 27 Nov 2018 Planned initiation date (Estimated date of first participant enrollement ) changed from 26 Nov 2018 to 3 Dec 2018.
    • 20 Nov 2018 Planned initiation date (Estimated date of first participant enrollement ) changed from 1 Nov 2018 to 26 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top